Healthcare -
Biotechnology - NASDAQ - US
$ 1.045
-6.7 %
$ 119 M
Market Cap
-0.64
P/E
FATE - PRE-TAX INCOME
Pre-tax Income FATE - Fate Therapeutics, Inc.
-161 M
LAST VALUE
12.90%
2 YEAR CAGR
-19.30%
5 YEAR CAGR
-22.65%
10 YEAR CAGR